Literature DB >> 33484771

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.

C Wendy Spearman1, Hailemichael Desalegn2, Ponsiano Ocama3, Yaw Asante Awuku4, Olusegun Ojo5, Medhat Elsahhar6, Abdulmunem A Abdo7, Dennis Amajuoyi Ndububa8, Yasser Fouad9, Musa Muhammed Borodo10, Masolwa Ng'wanasayi11, Reidwan Ally12, Reda Elwakil13.   

Abstract

Entities:  

Keywords:  Africa; Delphi; MAFLD; NAFLD

Year:  2021        PMID: 33484771     DOI: 10.1016/j.jhep.2021.01.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future.

Authors:  Ting-Yao Wang; Jacob George; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

Review 2.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

3.  Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia.

Authors:  Belinda Varaidzo Chihota; Carlotta Riebensahm; Guy Muula; Edford Sinkala; Roma Chilengi; Lloyd Mulenga; Samuel Bosomprah; Michael J Vinikoor; Carolyn Bolton-Moore; Matthias Egger; Andri Rauch; Annalisa Berzigotti; Gilles Wandeler
Journal:  BMJ Open Gastroenterol       Date:  2022-07

4.  Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.

Authors:  Jia-Ying Wei; Zhou Xu; Hao Li; Wen-Qin Du; Bai-Ling Niu; Shu Li; Shen Tian; Juan Wu; Yu-Ling Chen; Xin Li; Zi-Li Liu; Jun Xiao; Guo-Sheng Ren; Liang Ran; Ling-Quan Kong
Journal:  Int J Med Sci       Date:  2021-06-22       Impact factor: 3.738

Review 5.  Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science.

Authors:  Yasser Fouad; Melissa Palmer; Minjun Chen; Arie Regev; Rajarshi Banerjee; Rob Myers; Robert Riccio; Richard Torstenson; Ramy Younes; Puneet S Arora; Henrik Landgren; Morten A Karsdal; Martin Blake; David A Shapiro; Hans-Juergen Gruss; Muhammad Y Sheikh; Dina Attia; Steven Bollipo; Alastair D Smith; Bradley Freilich; Robert G Gish; Detlef Schuppan
Journal:  J Clin Transl Hepatol       Date:  2021-10-22

Review 6.  Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease.

Authors:  Huapeng Lin; Xinrong Zhang; Guanlin Li; Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  J Clin Transl Hepatol       Date:  2021-08-30

7.  Metabolic-associated Fatty Liver Disease.

Authors:  Ming-Hua Zheng
Journal:  J Clin Transl Hepatol       Date:  2021-11-09

8.  Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study.

Authors:  Cheng Yu; Minzhen Wang; Shan Zheng; Miao Xia; Hongyan Yang; Desheng Zhang; Chun Yin; Ning Cheng; Yana Bai
Journal:  J Clin Transl Hepatol       Date:  2021-07-01

9.  MAFLD Not NAFLD is Associated with Impairment of Health-related Quality of Life.

Authors:  Dina Attia; Nadia Abdel Aty; Ahmed Shawket; Ebada Said; Yasser Fouad
Journal:  J Clin Transl Hepatol       Date:  2021-11-25

Review 10.  MAFLD enhances clinical practice for liver disease in the Asia-Pacific region.

Authors:  Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Mohammed Eslam; Jacob George; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.